|
DMRA Damora Therapeutics Inc 1800315 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-31,174,000.00 |
| Balance Sheet |
|
Current Assets
|
$543,588,000.00 |
|
Assets
|
$543,636,000.00 |
|
Current Liabilities
|
$27,550,000.00 |
|
Liabilities
|
$27,577,000.00 |
|
Equity
|
$516,059,000.00 |
|
Shares Out
|
61734601.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,465,000.00 |
|
Investing Cash Flow
|
$-17,374,000.00 |
| Market Analysis |
Market Cap
|
$1,871,175,756.31 |
|
Price
|
$30.31 |
|
BVPS
|
8.36 |
|
PB
|
3.63 |
|
EPS
|
-0.39 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:23 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DMRA documents filed with the SEC.
DMRA Filings
Clear
